London’s Science Museum Displays Breakthrough Stem Cell Sprayer

Hand-held device uses patient’s own cells to treat severe burns.

London’s Science Museum collection houses a record of the scientific, medical and technological achievements from around the world. Although the historical record is well represented, it also offers its nearly 3 million annual visitors a glimpse of what’s on the horizon at its Tomorrow’s World Gallery. Among future technologies and promising breakthroughs currently on exhibit is RenovaCare’s SkinGun™ Stem Cell Sprayer, the company’s technology that isolates and then sprays a patient’s own stem cells onto burn and wounds. promoting accelerated healing and lessening the chance of infection.

Although not yet approved by the FDA, RenovaCare said this is the first public display of its SkinGun and CellMistTM system used for isolating a burn victim’s cells to use therapeutically. A prior version, said RenovaCare, has been used successfully to treat burns and wounds from gas and chemical explosions, electrocution, exposure to high-temperature liquids and flames fueled by various combustibles.

According to RenovaCare, it only takes about 90 minutes to isolate a burn victim’s stem cells from a small (square inch) sample of healthy skin tissue and prepare a saline suspension for spraying on the wound. Citing the case of a State Trooper severely burned in the line of duty, RenovaCare said that because of SkinGun stem-cell treatment, the officer was able to leave the hospital in “only a few days” as opposed to the weeks and months in and out of hospitals associated with using skin grafts and surgeries to treat and heal burn wounds.

RenovaCare explained that the market for an alternative treatment to burn and wound treatments is projected to be a promising $45 billion in the U.S. alone.


Guy Tiene

Guy supports the success of life science organizations by identifying synergies across research, content, marketing and communications resources to drive value for clients. With over 30 years of education and marketing experience and 18 years in the life sciences alone, Guy leads our editorial standards for client content, Pharma’s Almanac and Nice Insight research-based industry content as well as external communications for clients. Having served as head of global marketing and communications for a CMO, he also brings critical insight and guidance to all communications. Guy holds a Masters degree from Columbia University.